drugset / Trial / NCT01441531

Efficacy of Gabapentin in Prevention of Tourniquet Pain and Hypertension

NCT01441531

Phase 0 Withdrawn Baylor College of Medicine
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of the study is to find out if taking a dose of gabapentin 600 mg by mouth (po) before surgery will help prevent the development of tourniquet pain and hypertension while the tourniquet is inflated during orif of tibia fracture.

Timeline

Start
2012-01
Primary completion
2014-06
Completion
2014-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Gabapentin Small molecule 600 mg Oral

Indications

No indication recorded.